Latest Trevena Inc. Stories
Heptares Extends Global Patent Protection for GPCR-Focused Drug Discovery Platform With Grant of Core Patents in the United States
LONDON and BOSTON, December 15, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, is pleased to announce
Word of the Day
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.
The word 'taphephobia' comes from Greek roots meaning 'burial' and 'fear'.